⌘K

Login Start Free

Home/Filings/4/0001261380-16-000083

4//SEC Filing

IRIDEX CORP 4

Accession 0001261380-16-000083

$IRIXCIK 0001006045operating

View on SEC.gov Company Profile

Filed

May 17, 8:00 PM ET

Accepted

May 18, 7:16 PM ET

Size

16.1 KB

Accession

0001261380-16-000083

Insider Transaction Report

Form 4

Period: 2016-05-17

IRIDEX CORPIRIX

VP, Operations

Transactions

Sale
Common Stock
2016-05-17$12.79/sh−1,250$15,993→ 65,625 total
Exercise/Conversion
Stock Option Right to Buy
2016-05-17−1,250→ 5,000 total
Exercise: $3.86From: 2013-02-01Exp: 2019-12-13→ Common Stock (1,250 underlying)
Sale
Common Stock
2016-05-17$12.82/sh−2,083$26,701→ 66,875 total
Exercise/Conversion
Common Stock
2016-05-17$3.99/sh+2,083$8,311→ 68,958 total
Exercise/Conversion
Common Stock
2016-05-17$3.86/sh+1,250$4,820→ 68,125 total
Sale
Common Stock
2016-05-17$12.82/sh−1,250$16,023→ 66,875 total
Exercise/Conversion
Stock Option Right to Buy
2016-05-17−2,083→ 0 total
Exercise: $3.99From: 2013-04-16Exp: 2019-04-16→ Common Stock (2,083 underlying)

Footnotes (5)

[F1]The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $12.67 to $12.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
[F2]The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $12.67 to $12.9 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
[F3]This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
[F4]The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.
[F5]The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

IRIDEX CORP

CIK 0001006045

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001006045

Filing Metadata

Form type: 4
Filed: May 17, 8:00 PM ET
Accepted: May 18, 7:16 PM ET
Size: 16.1 KB

View on SEC.gov